Published 07/31/2018

BUFFALO, N.Y. (PRWEB) July 31, 2018

ZeptoMetrix® Corporation (ZMC) announced today the release of 2 additional IVD CE marked molecular quality controls to its expanding CE IVD product inventory. Below is a quote from the CEO of ZeptoMetrix explaining more about our new IVD molecular controls:

“We are pleased today to introduce two Group B Streptococcus molecular quality controls to our expanding IVD/CE QC offerings. ZeptoMetrix remains entirely committed to fully support and provide our diagnostics industry with as many precise and dependable, non-infectious tools as we can to assist with accurate and reliable QC”, explains Shawn Smith, President and CEO of ZeptoMetrix.

Dedicated to strengthening its IVD/CE core, ZeptoMetrix has utilized its patented NATtrol™ inactivation treatment to provide the following GBS (Group B Streptococcus) IVD/CE molecular quality controls:

NATtrol GBS Positive Control # MDZ053
NATtrol GBS Negative Control # MDZ054

Together, the routine and repetitive use of NATtrol™ External Run Controls and Range Verification Panels enables laboratories to verify test performance, track and monitor daily test variation, lot-to-lot test kit performance and individual operator performance to provide assistance in identifying trends in laboratory results and ultimately improving IVD quality controls.

Welcome To